ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Adeona Pharmaceuticals Common Stock

Adeona Pharmaceuticals Common Stock (AEN)

0.00
0.00
(0.00%)
Cerrado 24 Enero 3:00PM
0.00
0.00
(0.00%)
Fuera de horario: -

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
-
Postura de Compra
-
Postura de Venta
-
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
-
Precio de Apertura
-
Hora
Última hora de negociación
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

AEN Últimas noticias

Adeona Becomes Synthetic Biologics, Inc.

Adeona Becomes Synthetic Biologics, Inc. -- New Name Reflects Biotechnology Company Focus on the Emerging Field of Synthetic Biologics -- -- New NYSE Amex Ticker Symbol: SYN -- PR Newswire ANN...

Adeona CEO to Present at the Harvard Investors Group Forum

Adeona CEO to Present at the Harvard Investors Group Forum PR Newswire ANN ARBOR, Mich., Feb. 9, 2012 ANN ARBOR, Mich., Feb. 9, 2012 /PRNewswire/ -- Adeona Pharmaceuticals, Inc. (NYSE Amex: AEN...

Adeona Appoints C. Evan Ballantyne as Chief Financial Officer

Adeona Appoints C. Evan Ballantyne as Chief Financial Officer -- Former CFO of Clinical Data, Inc. Brings Extensive Financial Background to Emerging Synthetic Biologics Company -- PR Newswire ANN...

Adeona Announces Executive Management Transitions and Board of Directors Appointments to Strengthen Company's Synthetic Biolo...

Adeona Announces Executive Management Transitions and Board of Directors Appointments to Strengthen Company's Synthetic Biologics Strategic Focus -- Adeona Chairman, Jeff Riley, Appointed New...

Adeona Announces Initiation of Phase II Clinical Trial of Trimesta™ for Cognitive Dysfunction in Multiple Sclerosis

Adeona Announces Initiation of Phase II Clinical Trial of Trimesta™ for Cognitive Dysfunction in Multiple Sclerosis PR Newswire ANN ARBOR, Mich., Jan. 19, 2012 ANN ARBOR, Mich., Jan. 19, 2012...

Adeona Announces Proposed Name Change to Synthetic Biologics, Inc., and Appointment of John Monahan, Ph.D., as Senior Vice Pr...

Adeona Announces Proposed Name Change to Synthetic Biologics, Inc., and Appointment of John Monahan, Ph.D., as Senior Vice President of Research & Development -- Name Change Reflects Primary...

Positive Clinical Study Results Reported by Adeona's Oral Zinc for ALS Collaborator

Positive Clinical Study Results Reported by Adeona's Oral Zinc for ALS Collaborator -- PNA Center for Neurological Research Clinical Study Results Presented at the 22nd International Symposium on...

Adeona Pharmaceuticals and Intrexon Announce Worldwide Exclusive Collaboration for Synthetic DNA-based Therapy for Pulmonary ...

Adeona Pharmaceuticals and Intrexon Announce Worldwide Exclusive Collaboration for Synthetic DNA-based Therapy for Pulmonary Arterial Hypertension PR Newswire ANN ARBOR, Mich., and GERMANTOWN...

Adeona Reports Third Quarter 2011 Financial Results

Adeona Reports Third Quarter 2011 Financial Results -- Clinical Trial for Cognitive Dysfunction in Multiple Sclerosis Recruiting Patients -- PR Newswire ANN ARBOR, Mich., Nov. 14, 2011 ANN ARBOR...

Adeona and the Skirball Foundation Join Forces to Advance Multiple Sclerosis Research

Adeona and the Skirball Foundation Join Forces to Advance Multiple Sclerosis Research PR Newswire ANN ARBOR, Mich., Nov. 11, 2011 ANN ARBOR, Mich., Nov. 11, 2011 /PRNewswire/ -- Adeona...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

AEN - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de ?
El precio actual de las acciones de es US$ 0.00
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de ?
ha negociado en un rango de US$ 0.00 a US$ 0.00 durante el último año

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
AAPYKurv Yield Premium Strategy Apple AAPL ETF
US$ 24.265
(0.00%)
0
AAPXT Rex 2X Long Apple Daily Target ETF
US$ 25.48
(0.00%)
0
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026
US$ 26.635
(0.00%)
0
AAAUGoldman Sachs Physical Gold ETF Shares
US$ 27.22
(0.00%)
0
AAAAlternative Access First Priority CLO Bond ETF
US$ 25.205
(0.00%)
0
AAPYKurv Yield Premium Strategy Apple AAPL ETF
US$ 24.265
(0.00%)
0
AAPXT Rex 2X Long Apple Daily Target ETF
US$ 25.48
(0.00%)
0
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026
US$ 26.635
(0.00%)
0
AAAUGoldman Sachs Physical Gold ETF Shares
US$ 27.22
(0.00%)
0
AAAAlternative Access First Priority CLO Bond ETF
US$ 25.205
(0.00%)
0
AAPYKurv Yield Premium Strategy Apple AAPL ETF
US$ 24.265
(0.00%)
0
AAPXT Rex 2X Long Apple Daily Target ETF
US$ 25.48
(0.00%)
0
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026
US$ 26.635
(0.00%)
0
AAAUGoldman Sachs Physical Gold ETF Shares
US$ 27.22
(0.00%)
0
AAAAlternative Access First Priority CLO Bond ETF
US$ 25.205
(0.00%)
0
DruidOracle55 DruidOracle55 5 minutos hace
What is their NET income for 2024? lets see how many people know what they invest in
IQST
Here Today Here Today 7 minutos hace
Seems like someone is attempting to wrestle away control of the company via majority ownership of the shares. That and there is between 12 - 14 % of total OS shorted that is being reported and not including any of the "Dark Pool - Never Covered" Shorted shares.
RNAZ
DruidOracle55 DruidOracle55 7 minutos hace
P&D in action-so predictable.
UMAV
DruidOracle55 DruidOracle55 9 minutos hace
So more BS
AXXA
DruidOracle55 DruidOracle55 11 minutos hace
Jason is just as real as James Bond
AXXA
DruidOracle55 DruidOracle55 11 minutos hace
Who is Jason?
AXXA
joeycav11 joeycav11 17 minutos hace
I think the reason to keep reiterating stock goes to a buck on mhra approval is to condition shareholders to sell if it opens at 2.50 Make them feel like they should consider taking some money off the table.
NWBO
bbotcs bbotcs 23 minutos hace
A third term for President Trump? https://www.yahoo.com/news/tennessee-republican-proposes-amendment-allow-000727320.html
bbotcs bbotcs 26 minutos hace
Gmenfan: That would be great. So would using more ngas!
bbotcs bbotcs 27 minutos hace
lj: oil
Trump wants cheap oil. Heard on TV tonight, right or wrong I don't know, that they would have to get the oil price down to $45 a barrel to force Russia's economy into major trouble. Stranger things have happened.
It is obvious that Trump is seeking cooperation from the Saudi
Investor2014 Investor2014 28 minutos hace
Highly inappropriate, unscientific and unfortunate, but fits the uniformity of the P2b/3 trial population and so for that reason may not be requiring further trials. I can see that would likely also be a fit with much of the poster population.

https://x.com/adamfeuerstein/status/18825
AVXL
TommyJ7651 TommyJ7651 34 minutos hace
I ran some numbers on Duparquet yesterday with all of the new information we have gotten from the drilling and also the current gold price environment. The current PEA is already outdated in the sense that the deposit has grown A LOT and the gold price has risen almost $1000 since then. They calcula
FFMGF
IVRT IVRT 37 minutos hace
You cannot be a stock trader. What do you actually do? You do not take into consideration the words you put to paper? Read what you typed to me. Boy, that is so left field. I have never traded a stock that I did not take a gamble on. The risk reward profile is what I use. Some risks are worth
BMXI
Gitzstv Gitzstv 37 minutos hace
NO DSGT PENNY SCAM AT THE PGA SHOW THIS YEAR BAHAHAHAHAHAHA 

PROBABLY BECAUSE BOB SILZER CAN'T USE IT TO PUMP THE WORTHLESS STOCK ANYMORE

YOU KNOW HE'D BE MILKING EVERY PR POSSIBLE TALKING ABOUT BOGUS DEALS AND CONTRACTS AND PROMISES TO BUY HIS FAKE CARTS AND EVs HAHAHA
DSGT
Nrdc92 Nrdc92 38 minutos hace
I find it amazing that such faith is put in one person/position. No CEO executes on his/her own. They put a strong team in place to execute the CEO's vision. They are supported by a strong board and a talented group of executives and front line employees. You simply can't switch out the CEO and say
LWLG
Gitzstv Gitzstv 44 minutos hace
THAT PENNY SCAMMING FRAUD LOST EVERYTHING LOL LOL LOL LOL REMEMBER WHEN HE BRAGGED ABOUT BUYING MORE AT 2 CENTS AND EVERY TIME IT DROPPED? HE CLAIMED TO HAVE BEEN BUYING ABOVE $1 ALSO HAHAHAHAHAHA AND SAID HE NEVER SOLD 1 SHARE.

I'M SURE HE THINKS BOB IS A GREAT CEO STILL AND IS SAD H
DSGT
IVRT IVRT 49 minutos hace
What's so special about BMXI trading flat? Been doing for months ain't it? That ain't news!
BMXI
nowwhat2 nowwhat2 49 minutos hace
That was a Do Or Die time there.............Elsewhere, we've been watching this thing form.


https://investorshub.advfn.com/uimage/uploads/2025/1/24/pfhrrSOL_1_23_1m_11-m_wild_wedge_ohtl.jpg


The dippings BENEATH the diagonal there.........THEY were the Do
Swammmie1040 Swammmie1040 54 minutos hace
Got a response to my email tonight from FDCT about the acquisitions of alchemy group and alchemy global and here’s their response.
https://stocktwits.com/Swammie/message/601285958
FDCT
QueenVic QueenVic 58 minutos hace
Where's the comma? Oddly has a space between the 2 and 6
FNMA
nickmerck nickmerck 1 hora hace
because RCAT was always going to be an exit vehicle, and he got out at the best time. Others are probably selling into this as well. Just look at the financials: their margins don't increase with increasing revenues, they don't invest into infrastructure (which would explain the former), and their b
RCAT
ORBAPU ORBAPU 1 hora hace
Well they said nothing about IPE that I saw. Pretty thin gruel
AMRN
nowwhat2 nowwhat2 1 hora hace
That was a Do Or Die time there.............Elsewhere, we've been watching this thing form.


https://investorshub.advfn.com/uimage/uploads/2025/1/24/pfhrrSOL_1_23_1m_11-m_wild_wedge_ohtl.jpg


The dippings BENEATH the diagonal there.........THEY were the Do
BTCUSD
lovethatgreen lovethatgreen 1 hora hace
Possibly
But I wouldn't jump so fast that's it s a scam. They show they have someone that worked for the fda overseeing the BTD submission. That in itself is significant as long as they actually submit the application. It appears they are indeed moving that direction.
Also these su
ADHC